US · Healthcare

Finch Therapeutics Group Inc (FNCH)

Biotechnology

Finch Therapeutics Group Inc (FNCH) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for FNCH

P/E ratio

25.00

Finch Therapeutics Group Inc (FNCH) — FAQ

What is FNCH's P/E ratio?

The price-to-earnings (P/E) ratio for Finch Therapeutics Group Inc (FNCH) is 25.00 (data as of 2026-05-23).

Does Finch Therapeutics Group Inc pay a dividend?

Dividend yield is not available in the current snapshot for Finch Therapeutics Group Inc (FNCH). Check the MyAverix Finance app for the latest dividend data.

What sector is Finch Therapeutics Group Inc in?

Finch Therapeutics Group Inc (FNCH) is classified in the Healthcare sector (Biotechnology industry).

What exchange is FNCH listed on?

FNCH is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)